Effect of different culture conditions on establishment of embryonic stem cells from BALB/cAJ and NZB/BINJ mice

Cellular Reprogramming

Volumn 12, Issue 6, 2010, Pages 679-688

  Iijima, Saori ^a   Tanimoto, Yoko ^a   Mizuno, Seiya ^a   Daitoku, Yoko ^a   Kunita, Satoshi ^a   Sugiyama, Fumihiro ^a   Yagami, Ken Ichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ARTICLE; BAGG ALBINO MOUSE; BLASTOCYST; CELL GROWTH; CELL LINEAGE; CHROMOSOME NUMBER; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; EMBRYO CULTURE; EMBRYONIC STEM CELL; FIBROBLAST; GERM LINE; INBRED STRAIN; INNER CELL MASS; MOUSE; MOUSE STRAIN; NEW ZEALAND BLACK MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHIMERA; COCULTURE TECHNIQUES; CULTURE MEDIA; EMBRYONIC STEM CELLS; FEMALE; HUMANS; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NZB;

MUS;

EID: 78649524937     PISSN: 21524971     EISSN: 21524998     Source Type: Journal    
DOI: 10.1089/cell.2010.0018     Document Type: Article

References (33)

1. Araki, K., Takeda, N., Yoshiki, A., et al. (2009). Establishment of germline-competent embryonic stem cell lines from the MSM/ Ms strain. Mamm. Genome 20, 14-20.
2. Baharvand, H., and Matthaei, I.K. (2004). Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains. In Vitro Cell. Dev. Biol. Anim. 40, 76-81.
3. Bain, J., Plater, L., Elliott, M., et al. (2007). The selectivity of protein kinase inhibitors; a further update. Biochem. J. 408, 297-315.
4. Batlle-Morera, L., Smith, A., and Nichols, J. (2008). Parameters influencing derivation of embryonic stem cells from murine embryos. Genesis 46, 758-767.
5. Brons, I.G., Smithers, L.E., Trotter, M.W., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191-195.
6. Buehr, M., Meek, S., Blair, K., et al. (2008). Capture of authentic embryonic stem cells from rat blastocysts. Cell 135, 1287-1298.
7. Chambers I., Silva, J., Colby, D., et al. (2007). Nanog safeguards pluripotency and mediates germline development. Nature 450 1230-1234.
8. Chou, Y.F., Chen, H.H., Eijpe, M., et al. (2008). The growth factor environment defines distinct pluripotent ground states in novel blastocysts-derived stem cells. Cell 135, 449-461.
9. Davies, P.S., Reddy, H., Caivano, M., et al. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95-105.
10. Dinkel, A., Aicher, W.K., Warnatz, K., et al. (1999). Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells. J. Immunol. Methods 223, 255-260.
11. Doetschman, T., Gregg, R.G., Maeda, N., et al. (1987). Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330, 576-578.
12. Evans, M.J., and Kaufman, M.H. (1981). Establishment in culture of pluripotential stem cells from mouse embryos. Nature 292, 154-156.
13. Hanna, J., Markoulaki, S., Mitalipova, M., et al. (2009). Me-tastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4, 1-12.
14. Hooper, M., Hardy, K., Handyside, A., et al. (1987). HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germ-line colonization by cultured cells. Nature 326, 295-298.
15. Kuehn, M.R., Bradley, A., Robertson, E.J., et al. (1987). A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326, 295-298.
16. Lemckert, F.A., Sedgwick, J.D., and Korner, H. (1997). Gene targeting in C57BL/6 ES cells. Successful germ line transmission using recipient BALB/c blastocysts developmentally mutated in vitro. Nucleic Acids Res. 25, 917-918.
17. Li, P., Tong, C., Mehrian-Shai, R., et al. (2008). Germline competent embryonic stem cells derived from rat blastocysts. Cell 135, 1299-1310.
18. Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by terato-carcinoma cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638.
19. Mohammad, M., McMahon, G., Sun, L., et al. (1997). Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276, 955-960.
20. Nichols, J., Jones, K., Phillips, J.M., et al. (2009). Validated germline-competent embryonic stem cell lines from nonobense diabetic mice. Nat. Med. 15, 814-818.
21. Niwa, H., Ogawa, K., Shimosato, D., et al. (2009). A parallel circuit of LIF signaling pathways maintains pluripotency of mouse ES cells. Nature 460, 118-122.
22. Ohta, H., Ohinata, Y., Ikawa, M., et al. (2009). Male germline and embryonic stem cell lines from NOD mice: efficient derivation of GS cells from a nonpermissive strain for ES cell derivation. Biol. Reprod. 81, 1147-1153.
23. Ring, B.D., Johnson, W.K., Henriksen, J.E., et al. (2003). Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52, 588-595.
24. Shimizukawa, R., Sakata, A., Hirose, M., et al. (2005). Establishment of a new embryonic stem cell line derived from C57BL/6 mouse expressing EGFP ubiquitously. Genesis 42, 47-52.
25. Smith, A.G., Heath, J.K., Donaldson, D.D., et al. (1988). Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688-690.
26. Stevens, L.C. (1973). A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J. Natl. Cancer Inst. 50, 235-242.
27. Tanimoto, Y., Iijima, S., Hasegawa, Y., et al. (2008). Embryonic stem cells derived from C57BL/6J and C57BL/6N mice. Comp. Med. 58, 347-352.
28. Tesar, P.J., Chenoweth, J.G., Brook, F.A., et al. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196-199.
29. Thomas, K.R., and Capecchi, M.R. (1987). Site-directed muta-genesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
30. Williams, R.L., Hilton, D.J., Pease, S., et al. (1988). Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 365, 87-89.
31. Wood, S.A., Allen, N.D., Rossant, J., et al. (1993). Non-injection methods for the production of embryonic stem cell-embryo chimeras. Nature 365, 87-89.
32. Yagi, T., Tokunaga, T., Furuta, Y., et al. (1993). A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214, 70-76.
33. Ying, Q.L., Wray, J., Nichols, J., et al. (2008). The ground state of embryonic stem cell self-renewal. Nature 453, 519-523.